Related Experiment Video
Updated: Nov 19, 2025

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Update on the Role of High-Flow Nasal Cannula in Infants with Bronchiolitis
Valentina Fainardi1, Lara Abelli1, Maria Muscarà1
1Pediatric Clinic, Pietro Barilla Children's Hospital, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
Insights
High-flow nasal cannula (HFNC) is increasingly used for bronchiolitis (BR) in infants. While safe for mild to moderate cases, clear guidelines are needed to define its role versus standard oxygen therapy and other noninvasive methods.
Area of Science:
- Pediatrics
- Respiratory Medicine
- Infectious Diseases
Background:
- Bronchiolitis (BR), primarily caused by RSV, is a common severe lower respiratory tract infection in infants.
- Current treatments for BR include nutritional support and oxygen therapy, with standard oxygen therapy (SOT) for mild cases and invasive mechanical ventilation (IMV) for severe cases.
- Noninvasive ventilation methods like BiPAP, CPAP, and HFNC have emerged to improve oxygen delivery and avoid IMV.
Purpose of the Study:
- To review the role of high-flow nasal cannula (HFNC) in treating infants with bronchiolitis (BR).
- To analyze the current literature on HFNC efficacy and its comparison with other oxygenation methods for BR.
- To identify the need for consistent guidelines regarding HFNC initiation and discontinuation in pediatric BR management.
Main Methods:
- This study is a narrative review of existing literature on HFNC use in infant bronchiolitis.
- The review analyzes clinical studies and reports on the effectiveness, tolerability, and safety of HFNC.
- Literature was examined to assess HFNC's role in preventing respiratory failure and its comparative benefits against SOT, CPAP, and BiPAP.
Main Results:
- High-flow nasal cannula (HFNC) is widely adopted for its simplicity, safety, and good tolerability in treating BR.
- Despite widespread use, the precise role of HFNC in preventing respiratory failure in pediatric BR is not clearly defined.
- Evidence is insufficient to establish if HFNC offers superior benefits over standard oxygen therapy (SOT) or when it can replace CPAP or BiPAP.
Conclusions:
- High-flow nasal cannula (HFNC) is a safe and effective option for mild to moderate bronchiolitis (BR) unresponsive to standard oxygen therapy (SOT).
- There is a significant need for multicenter studies and official clinical guidelines to standardize HFNC use in pediatric BR.
- Further research is required to precisely define HFNC's benefits compared to SOT and its optimal role relative to CPAP and BiPAP in BR management.
Abstract:
Bronchiolitis (BR), a lower respiratory tract infection mainly caused by respiratory syncytial virus (RSV), can be very severe. Presently, adequate nutritional support and oxygen therapy remain the only interventions recommended to treat patients with BR. For years, mild BR cases were treated with noninvasive standard oxygen therapy (SOT), i.e., with cold and poorly or totally non-humidified oxygen delivered by an ambient headbox or low-flow nasal cannula. Children with severe disease were intubated and treated with invasive mechanical ventilation (IMV). To improve SOT and overcome the disadvantages of IMV, new measures of noninvasive and more efficient oxygen administration have been studied. Bi-level positive air way pressure (BiPAP), continuous positive airway pressure (CPAP), and high-flow nasal cannula (HFNC) are among them. For its simplicity, good tolerability and safety, and the good results reported in clinical studies, HFNC has become increasingly popular and is now widely used. However, consistent guidelines for initiation and discontinuation of HFNC are lacking. In this narrative review, the role of HFNC to treat infants with BR is discussed. An analysis of the literature showed that, despite its widespread use, the role of HFNC in preventing respiratory failure in children with BR is not precisely defined. It is not established whether it can offer greater benefits compared to SOT and when and in which infants it can replace CPAP or BiPAP. The analysis of the results clearly indicates the need for multicenter studies and official guidelines. In the meantime, HFNC can be considered a safe and effective method to treat children with mild to moderate BR who do not respond to SOT.
More Related Videos
Related Concept Videos
Administering Oxygen by Nasal Cannula
Nasal Cannulas
A nasal cannula is a lightweight tube split into two prongs placed in the nostrils,...
Oxygen Delivering System I: Nasal Cannula and Face Mask
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Suctioning the Nasopharyngeal Airway
Equipment Required
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...

